Procurenet

FTC 200mg+TDF 300mg Tablets - Quality Treatment for HIV-1 Infections

Product: HIV-1 Infection Control FTC 200mg+TDF 300mg Tablets.

  • Active Ingredients: Emtricitabine 200mg (NRTI), Tenofovir Disoproxil Fumarate 300mg (NtRTI).
  • Function: Combinatorial action inhibits HIV-1 replication effectively.
  • Key Usage: Suitable for usage with or without meals.
  • Storage: Safe storage under 30u00b0C (86u00b0F) in secure container.
  • Safety: Child-proof packaging keeps medicament out of children’s reach and sight.
Quantity
Delivery options
  • Ship Only

Description

FTC 200mg+TDF 300mg Tablets

Designed to control HIV-1 infections, our FTC 200mg+TDF 300mg Tablets exceed global health standards in the fight against HIV-1. With 200mg of Emtricitabine and 300mg of Tenofovir Disoproxil Fumarate (equivalent to 245mg of Tenofovir Disoproxil) in every tablet, these are vital medication in the treatment protocols for HIV-1.

Key Product Features:

  • CAS Number: Emtricitabine: 143491-57-0; Tenofovir Disoproxil Fumarate: 202138-50-9.
  • Molecular Formula: Emtricitabine: C8H10FN3O3S; Tenofovir Disoproxil Fumarate: C19H30N5O10P.
  • Molecular Weight: Emtricitabine: 247.24 g/mol; Tenofovir Disoproxil Fumarate: 635.51 g/mol.
  • Solubility: Emtricitabine: 112 mg/mL (in water); Tenofovir Disoproxil Fumarate: 13.4 mg/mL (in water).
  • Pharmacological Class: Emtricitabine: Nucleoside Reverse Transcriptase Inhibitor (NRTI); Tenofovir: Nucleotide Reverse Transcriptase Inhibitor (NtRTI).
  • Storage: Keep below 30 °C (86 °F) in a closed container and out of the reach of children.
  • Shelf Life: The tablets have a standard two-year shelf life (24 months).
  • Usage: Take orally as instructed by your healthcare provider. Consistency in treatment is crucial for optimal results.

Our FTC 200mg+TDF 300mg Tablets are recommended by the WHO and other health guidelines, making them a reliable treatment option for HIV-1 infections. The tablets can be used as a standalone treatment or in combination with other drugs, offering flexibility in the treatment. To stay current with usage recommendations, please consult the WHO treatment guidelines or your regional national guidelines.

Customer reviews

Share your thoughts with other customers

Be the first one to write a review!